INS and Hyperglycemia: An earlier study that used an intramuscular injection of rAAV-lep produced circulating leptin levels of 2–5 ng/mL and was capable of reducing food intake, body weight, hyperglycemia and insulin levels in leptin-deficient ob/ob mice for a 6-month period [40].